Affiliation:
1. Centre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada
2. Department of Surgery (Urology), Faculty of Medicine, Laval University, Quebec, QC G1R 2J6, Canada
Abstract
Prostate cancer (PCa) displays diverse intra-tumoral traits, impacting its progression and treatment outcomes. This study aimed to refine PCa cell culture conditions for dynamic monitoring of androgen receptor (AR) activity at the single-cell level. We introduced an extracellular matrix-Matrigel (ECM-M) culture model, enhancing cellular tracking during bioluminescence single-cell imaging while improving cell viability. ECM-M notably tripled the traceability of poorly adherent PCa cells, facilitating robust single-cell tracking, without impeding substrate permeability or AR response. This model effectively monitored AR modulation by antiandrogens across various PCa cell lines. Single-cell imaging unveiled heterogeneous antiandrogen responses within populations, correlating non-responsive cell proportions with drug IC50 values. Integrating ECM-M culture with the PSEBC-TSTA biosensor enabled precise characterization of ARi responsiveness within diverse cell populations. Our ECM-M model stands as a promising tool to assess heterogeneous single-cell treatment responses in cancer, offering insights to link drug responses to intracellular signaling dynamics. This approach enhances our comprehension of the nuanced and dynamic nature of PCa treatment responses.
Funder
PCC Movember New investigator pilot
Rising Star
Canadian Urological Association Scholarship Funds
Fonds de recherche du Québec—Santé (FRQS) for clinician-scientists
John R. Evans Leaders Fund from Canadian Foundation for Innovation
Cancer Research Society and Astellas Canada for the development of a real-time dynamic bioluminescent microscopy platform
Fonds de recherche du Québec-Santé
Fondation du CHU de Québec